OneMedNet Corp

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OneMedNet Corp. designs and develops clinical imaging technology for the healthcare sector. It offers OneMedNet iRWD, a solution that securely de-identifies, searches, curates and shares medical images data with patients, care providers, and hospitals. The company was founded by Jeffrey N. Yu in 2009 and is headquartered in Eden Prairie, MN.

MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade Real World Data (RWD) including electronic health records, laboratory results, and medical imaging, has announced an additional strategic investment in Bitcoin. This investment is designed to enhance the company's financial resilience and support the expansion of its cutting-edge iRWD™ platform.

OneMedNet Announces Continued Investment into Bitcoin

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This move reinforces our commitment to dynamic leadership and active engagement as we accelerate growth in this new phase.

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into a securities purchase agreement with an affiliate of Off the Chain Capital (collectively, “Off the Chain”) in a follow-on private placement that resulted in gross proceeds of approximately $1.7 million, before deducting fees and expenses payable by the Company.

OneMedNet Announces Additional $1.7 Million Private Placement

MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the “First Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the Company's failure to timely file its Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.

OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q

MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors.

OneMedNet appoints new CFO

MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation, coupled with other changes undertaken by the Company, has significantly reduced OneMedNet's operational costs, enabling the company to process vast amounts of clinical data in minutes rather than hours. Additionally, OneMedNet can now deliver longitudinal clinical data and images to Life Science organizations up to five times faster than before, as measured from the end-to-end data curation process, significantly expediting delivery.

OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X

Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management

OneMedNet Announces $4.6 Million Private Placement

Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies

Cytel Unveiled as OneMedNet's Newest Alliance Partner

Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

Secures new life science company customer through this globally recognized and trusted new channel Secures new life science company customer through this globally recognized and trusted new channel

OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining AWS Partner Network

Healthcare data management firm OneMedNet (NASDAQ: ONMD ) saw its shares skyrocket on Thursday, gaining over 150%. Management recently announced a greater than five-fold expansion of its proprietary data network.

Why Is OneMedNet (ONMD) Stock Up 150% Today?

Minneapolis, Minnesota--(Newsfile Corp. - May 2, 2024) - OneMedNet Corporation (NASDAQ: ONMD), is the leading curator of precision curated regulatory-grade Real World Data (“RWD”), will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The Plaza Hotel in New York. Aaron Green, President & CEO and Dr. Jeffrey Yu, Founder & CMO, will be presenting on May 15th.

OneMedNet Corporation Announces Participation in the EF Hutton Annual Global Conference

~ Validates OneMedNet's Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~ MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced that it has accepted an invitation to join ClinEco Inc., a connectivity platform and community environment, which improves access and expands distribution while promoting streamlined partner interactions and accelerated clinical innovation. “We are excited to be invited to join this vibrant clinical trial community, which validates that our Real World Data platform is a trusted source for precision regulatory grade clinical data (RWD),” stated Aaron Green, OneMedNet President and CEO.

OneMedNet Joins ClinEco Community of Clinical Research Industry Members

Cash Infusion Provides Significant Cash Runway of Up to $4.54 Million Cash Infusion Provides Significant Cash Runway of Up to $4.54 Million

OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth

~ President, Aaron Green, Assumes Role of Chief Executive Officer ~ ~ CEO, Paul Casey, Announces Retirement and Shift to Active Advisory Role to Guide Transition Successfully ~ ~ Casey to Remain on Board Post-Transition ~ MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade imaging Real World Data (“iRWD™”), today announced that its President, Aaron Green, has assumed the role of President and Chief Executive Officer, in addition to an appointment to OneMedNet's Board of Directors. Mr. Green will succeed CEO, Paul Casey, who has announced his retirement and who will continue to serve on the Board of Directors.

OneMedNet Announces CEO Succession Plan

MINNEAPOLIS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), is receiving an enthusiastic response from attendees at the 15th Annual SCOPE Summit.

OneMedNet iRWD® Draws Attention at Clinical Trials Meeting

MINNEAPOLIS, Feb. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced a growth initiative supporting women's health research. The company is seeing increasing business and new opportunities from Life Science innovators including leading pharmaceutical companies requiring RWD for women's health programs and has already filled multiple orders.

OneMedNet Sees Real World Data Growth in Women's Health

OneMedNet (NASDAQ: ONMD ) stock is taking off on Monday despite a lack of news from the health data sharing technology company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today.

Why Is OneMedNet (ONMD) Stock Up 169% Today?

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), today announced its participation as an exhibitor at the 15th Annual SCOPE Summit for Clinical Ops Executive (the “SCOPE Summit”) being held February 11-14, 2024 in Orlando, FL. OneMedNet's Founder and Chief Medical Officer Jeffrey Yu, President Aaron Green, and senior team members, will be on-site to discuss OneMedNet's iRWDTM solution at the SCOPE Summit's Real World Evidence track, available at Booth 228.

OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit

~ Partnership Reinforces RWD Leadership for Life Science Innovation ~ MINNEAPOLIS, MN / ACCESSWIRE / January 11, 2024 / OneMedNet Corporation, ("OneMedNet" or the "Company") (NASDAQ:ONMD) the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a partnership with Beacon Health System, Inc. to promote new patient care diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science organizations of all types are taking advantage of existing real world data within several product development stages including conceptualization, development, validation, regulatory approval, and post-market surveillance.

New Multi-Hospital Partner Joins OneMedNet's Expansive Real World Data Network

~ AWS Increases Life Sciences Accessibility to Industry Leading Regulatory-Grade Imaging Real World Data Platform ~ MINNEAPOLIS, MN / ACCESSWIRE / January 3, 2024 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that Amazon Web Services (AWS) customers can now procure highly curated and precise RWD on AWS Data Exchange, a digital marketplace that enables customers to search, purchase, and manage third party data directly on AWS. Expanded access through AWS augments utilization by Life Science organizations that rely on OneMedNet's RWD to accelerate time to market and lower the costs that correspond with diagnostic and therapeutic innovation.

OneMedNet iRWD(TM) Now Available on AWS Data Exchange

MINNEAPOLIS, MN / ACCESSWIRE / November 20, 2023 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced its Technical Exhibit during the Radiological Society of North America's ("RSNA") 2023 Annual Meeting from November 26 - 30, 2023 at McCormick Place in Chicago. OneMedNet's senior team will be on-site to display OneMedNet's iRWD™ solution via the Artificial Intelligence ("AI") Showcase in the South Hall A, Level 3, Exhibit Booth #4669.

OneMedNet Announces Participation as an Exhibitor in the AI Showcase During the RSNA 2023 Annual Meeting

~ Introduces OneMedNet's Exclusive iRWD™ Solution to a Global Community of Healthcare Professionals ~ MINNEAPOLIS, MN / ACCESSWIRE / November 10, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced that Aaron Green, President, and Betty Cosgrove, Area Vice President of Sales, will attend ISPOR Europe 2023, the leading global conference for Health Economics and Outcomes Research (HEOR). ISPOR Europe is being held November 12, 2023 through November 15, 2023, in Copenhagen, Denmark.

OneMedNet Announces Members of Senior Management to Attend ISPOR Europe 2023 Conference

~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~ MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-market surveillance.

News for OneMedNet Corp Stock (ONMD)